Stay updated with breaking news from Athersys Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The Cleveland-based regenerative medicine company said the split is aimed primarily at bringing it back into compliance with Nasdaq stock market requirements. The split will take place after the close of Nasdaq trading on Friday, Aug. 26.
The Business Research Company’s Soft Tissue Repair Global Market Report 2022: Market Size, Trends, And Forecast To 2026
The Cleveland-based biotechnology company on Monday, Aug. 15, said it has entered into a definitive agreement with a 'health care-focused U.S. institutional investor' for the sale of 48 million shares of the company's common stock at a price of 25 cents per share.
Corporate restructuring underway and MASTERS-2 clinical trial prioritizedConference call begins at 4:30 p.m. Eastern time todayCLEVELAND--(BUSINESS WIRE)--$ATHX #ARDS--Athersys, Inc. (NASDAQ: ATHX) announced today its financial results for the three and six months ended June 30, 2022 and provided a business update.S...
Press release content from Business Wire. The AP news staff was not involved in its creation.